Synapse - Works

Results (22057)

An open-label phase 1/2a study to evaluate the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of TRC253, an androgen receptor antagonist, in patients with metastatic castration-resistant prostate cancer (mCRPC)

Meeting Abstract

Rathkopf, D. E.; Saleh, M. N.; Tsai, F. Y. C.; Rosen, L. S.; Adams, B. J.; Liu, L.; Theuer, C. P.; Freddo, J. L.; Agarwal, N.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

EV-201 study: A single-arm, open-label, multicenter study of enfortumab vedotin for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor therapy

Meeting Abstract

Rosenberg, J. E.; Heath, E. I.; O'Donnell, P. H.; Hahn, N. M.; Balar, A. V.; Gartner, E. M.; Melhem-Bertrandt, A.; Petrylak, D. P.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Enfortumab vedotin (EV) in patients (Pts) with metastatic urothelial carcinoma (mUC) with prior checkpoint inhibitor (CPI) failure: A prospective cohort of an ongoing phase 1 study

Meeting Abstract

Petrylak, D. P.; Smith, D. C.; Flaig, T. W.; Zhang, J.; Sridhar, S. S.; Ruether, J. D.; Plimack, E. R.; Merchan, J. R.; Quinn, D. I.; Kilari, D.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Nomogram-based risk prediction of local and distant relapse after radical cystectomy, and role of perioperative chemotherapy, in patients with muscle-invasive bladder cancer (MIBC): A multicenter study

Meeting Abstract

Necchi, A.; Pond, G. R.; Plimack, E. R.; Niegisch, G.; Yu, E. Y.; Pal, S. K.; Bamias, A.; Agarwal, N.; Alva, A. S.; Srinivas, S.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Impact of number of cycles of platinum-based first-line chemotherapy for advanced urothelial carcinoma

Meeting Abstract

Necchi, A.; Mariani, L.; Lo Vullo, S.; Raggi, D.; Giannatempo, P.; Bamias, A.; Crabb, S. J.; Bellmunt, J.; Yu, E. Y.; Niegisch, G.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

IMmotion151: A randomized phase III study of atezolizumab plus bevacizumab vs sunitinib in untreated metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Motzer, R. J.; Powles, T.; Atkins, M. B.; Escudier, B.; McDermott, D. F.; Suarez, C.; Bracarda, S.; Stadler, W. M.; Donskov, F.; Lee, J. L.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

A phase 3 trial to compare efficacy and safety of lenvatinib in combination with everolimus or pembrolizumab versus sunitinib alone in first-line treatment of patients with metastatic renal cell carcinoma

Meeting Abstract

Motzer, R. J.; Grunwald, V.; Hutson, T. E.; Porta, C.; Powles, T.; Eto, M.; Dutcus, C. E.; Baig, M. A.; Dutta, L.; Li, D.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

c15-153: Randomized phase IB/II study of enzalutamide with and without ribociclib in patients with metastatic castrate resistant, chemotherapy naive prostate cancer that retains RB expression

Meeting Abstract

Kelly, W. K.; Godwin, J. L.; Hoffman-Censits, J. H.; Knudsen, K. E.; De Leeuw, R.; Leiby, B. E.; Southwell, T.; Hubert, C.; Smith, D. C.; Chatta, G. S.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

PSMA heterogeneity analysis in patients with metastatic castrate-resistant prostate cancer (mCRPC): Imaging versus CTCs

Meeting Abstract

Morris, M. J.; Vogelzang, N. J.; Sartor, A. O.; Armour, A. A.; Messmann, R. A.; Groaning, M.; Robarts, A.; Tolcher, A. W.; Gordon, M. S.; Babiker, H. M.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Adjuvant etoposide plus cisplatin (EP) for pathologic stage (PS) II nonseminomatous germ cell tumor (NSGCT)

Meeting Abstract

McHugh, D. J.; Funt, S.; Silber, D.; Knezevic, A.; Patil, S.; O'Donnell, D.; Tsai, S.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save